Ratio de rentabilidad sobre activos (ROA)
desde 2005
Cálculo
Illumina Inc., ROA, tendencias a largo plazocálculo
| ROA | = | 100 | × | Utilidad (pérdida) neta atribuible a los accionistas de Illumina1 | ÷ | Activos totales1 | |
|---|---|---|---|---|---|---|---|
| 31 dic. 2020 | 8.65% | = | 100 | × | 656) | ÷ | 7,585) |
| 29 dic. 2019 | 13.70% | = | 100 | × | 1,002) | ÷ | 7,316) |
| 30 dic. 2018 | 11.87% | = | 100 | × | 826) | ÷ | 6,959) |
| 31 dic. 2017 | 13.81% | = | 100 | × | 726) | ÷ | 5,257) |
| 1 ene. 2017 | 10.81% | = | 100 | × | 463) | ÷ | 4,281) |
| 3 ene. 2016 | 12.52% | = | 100 | × | 462) | ÷ | 3,688) |
| 28 dic. 2014 | 10.58% | = | 100 | × | 353) | ÷ | 3,340) |
| 29 dic. 2013 | 4.15% | = | 100 | × | 125) | ÷ | 3,019) |
| 30 dic. 2012 | 5.89% | = | 100 | × | 151) | ÷ | 2,566) |
| 1 ene. 2012 | 3.95% | = | 100 | × | 87) | ÷ | 2,196) |
| 2 ene. 2011 | 6.79% | = | 100 | × | 125) | ÷ | 1,839) |
| 3 ene. 2010 | 5.05% | = | 100 | × | 72) | ÷ | 1,430) |
| 28 dic. 2008 | 3.67% | = | 100 | × | 50) | ÷ | 1,377) |
| 30 dic. 2007 | -28.18% | = | 100 | × | (278) | ÷ | 988) |
| 31 dic. 2006 | 13.30% | = | 100 | × | 40) | ÷ | 301) |
| 1 ene. 2006 | -20.75% | = | 100 | × | (21) | ÷ | 101) |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).
1 US$ en millones
Comparación con la competencia
Illumina Inc., ROA, tendencias a largo plazo, comparación con los competidores
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 dic. 2020 | 8.65% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 7.72% | -10.18% | 6.23% | 20.47% | 9.23% |
| 29 dic. 2019 | 13.70% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | -32.34% | 9.72% | 14.29% | 6.33% |
| 30 dic. 2018 | 11.87% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | -19.61% | 7.00% | 20.83% | 5.22% |
| 31 dic. 2017 | 13.81% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 2.72% | — | 12.40% | 13.67% | 3.93% |
| 1 ene. 2017 | 10.81% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.11% | — | 4.20% | 12.84% | 4.40% |
| 3 ene. 2016 | 12.52% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.36% | — | 4.16% | 11.34% | 4.83% |
| 28 dic. 2014 | 10.58% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 12.12% | — | 5.40% | 8.99% | 4.42% |
| 29 dic. 2013 | 4.15% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 4.17% | — | 12.78% | 14.38% | 4.00% |
| 30 dic. 2012 | 5.89% | 19.53% | 8.00% | 5.46% | 7.26% | 11.89% | 12.20% | 8.94% | 5.81% | — | 7.84% | 36.06% | 4.29% |
| 1 ene. 2012 | 3.95% | — | 7.54% | 11.25% | 7.25% | 12.92% | 16.20% | 8.51% | 5.97% | — | 5.32% | -16.75% | 4.96% |
| 2 ene. 2011 | 6.79% | — | 10.64% | 9.98% | 8.07% | 16.35% | 25.03% | 12.96% | 0.81% | — | 4.23% | -9.59% | 4.85% |
| 3 ene. 2010 | 5.05% | — | 11.62% | 34.22% | 5.88% | 15.76% | 27.18% | 12.95% | 11.51% | — | 4.05% | -9.15% | 3.93% |
| 28 dic. 2008 | 3.67% | — | 11.51% | 17.76% | 7.53% | -7.09% | 28.65% | 15.25% | 16.54% | — | 7.29% | -12.34% | 4.71% |
| 30 dic. 2007 | -28.18% | — | 9.14% | 8.27% | 7.84% | 11.02% | 27.68% | 13.06% | 6.77% | — | 7.07% | -11.28% | 3.59% |
| 31 dic. 2006 | 13.30% | — | 8.73% | 6.20% | 8.72% | 12.13% | -29.12% | 15.67% | 9.95% | — | 16.84% | -17.49% | 0.79% |
| 1 ene. 2006 | -20.75% | — | 12.54% | 10.66% | 9.80% | 8.05% | 21.62% | 17.94% | 10.33% | — | 6.88% | -22.54% | 5.25% |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).
Comparativa con el sector industrial: Productos farmacéuticos, biotecnología y ciencias de la vida
Illumina Inc., ROA, tendencias a largo plazo, en comparación con el sector industrial: productos farmacéuticos, biotecnología y ciencias de la vida
| Illumina Inc. | Productos farmacéuticos, biotecnología y ciencias de la vida | |
|---|---|---|
| 31 dic. 2020 | 8.65% | 5.14% |
| 29 dic. 2019 | 13.70% | 8.90% |
| 30 dic. 2018 | 11.87% | 8.71% |
| 31 dic. 2017 | 13.81% | 5.27% |
| 1 ene. 2017 | 10.81% | 8.66% |
| 3 ene. 2016 | 12.52% | 9.03% |
| 28 dic. 2014 | 10.58% | 9.59% |
| 29 dic. 2013 | 4.15% | 9.55% |
| 30 dic. 2012 | 5.89% | 8.35% |
| 1 ene. 2012 | 3.95% | 7.32% |
| 2 ene. 2011 | 6.79% | 7.23% |
| 3 ene. 2010 | 5.05% | 10.17% |
| 28 dic. 2008 | 3.67% | 10.52% |
| 30 dic. 2007 | -28.18% | 8.98% |
| 31 dic. 2006 | 13.30% | 12.00% |
| 1 ene. 2006 | -20.75% | 10.50% |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).
Comparación con la industria: Atención médica
Illumina Inc., ROA, tendencias a largo plazo, en comparación con la industria: atención médica
| Illumina Inc. | Atención médica | |
|---|---|---|
| 31 dic. 2020 | 8.65% | 5.36% |
| 29 dic. 2019 | 13.70% | 7.15% |
| 30 dic. 2018 | 11.87% | 6.08% |
| 31 dic. 2017 | 13.81% | 5.31% |
| 1 ene. 2017 | 10.81% | 6.93% |
| 3 ene. 2016 | 12.52% | 7.37% |
| 28 dic. 2014 | 10.58% | 8.18% |
| 29 dic. 2013 | 4.15% | 8.29% |
| 30 dic. 2012 | 5.89% | 7.68% |
| 1 ene. 2012 | 3.95% | 7.00% |
| 2 ene. 2011 | 6.79% | 6.99% |
| 3 ene. 2010 | 5.05% | 9.19% |
| 28 dic. 2008 | 3.67% | 8.56% |
| 30 dic. 2007 | -28.18% | 8.18% |
| 31 dic. 2006 | 13.30% | 9.77% |
| 1 ene. 2006 | -20.75% | 9.09% |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).